Inventor
JOHNS BRIAN ALVIN
US29 patents
⚠️ This page may combine multiple inventors who share the name “JOHNS BRIAN ALVIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JOHNS BRIAN ALVIN
7 patentsUS8129385B2Mar 6, 2012
Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness
JOHNS BRIAN ALVIN66 citations97
US8410103B2Apr 2, 2013
(3S,11aR)-N-[2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide useful as anti-HIV agent
JOHNS BRIAN ALVIN33 citations95
US8580967B2Nov 12, 2013
Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate and processes for the preparation thereof
JOHNS BRIAN ALVIN8 citations91
US8552187B2Oct 8, 2013
Processes and intermediates for carbamoylpyridone HIV integrase inhibitors
JOHNS BRIAN ALVIN14 citations82
US8217034B2Jul 10, 2012
Chemical compounds
JOHNS BRIAN ALVIN18 citations82
US8183372B2May 22, 2012
Substituted 9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydor-1H-pyrido[1,2-a]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazines
JOHNS BRIAN ALVIN0 citations51
US8691991B2Apr 8, 2014
2-oxonaphthyridine-3-carboxamides HIV integrase inhibitors
JOHNS BRIAN ALVIN2 citations46
VIIV HEALTHCARE UK LTD
6 patentsUS9012642B2Apr 21, 2015
Pyrrolopyridinone compounds and methods for treating HIV
VIIV HEALTHCARE UK LTD36 citations90
US9802898B2Oct 31, 2017
Phenyl and tertbutylacetic acid substituted pyridinones having anti-HIV effects
VIIV HEALTHCARE UK LTD0 citations49
US10112899B2Oct 30, 2018
Isoindoline derivatives for use in the treatment of a viral infection
VIIV HEALTHCARE UK LTD1 citations45
US9163023B2Oct 20, 2015
Compounds and methods for treating HIV
VIIV HEALTHCARE UK LTD1 citations45
US10118894B2Nov 6, 2018
Isoindolinone derivatives useful as antiviral agents
VIIV HEALTHCARE UK LTD0 citations39
US10239840B2Mar 26, 2019
Benzoazepine derivatives
VIIV HEALTHCARE UK LTD0 citations34
SHIONOGI & CO
6 patentsUS9012650B2Apr 21, 2015
Substituted (3S, 11aR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamides of formula (I) useful as HIV agents
SHIONOGI & CO2 citations61
US9707246B2Jul 18, 2017
Substituted (3S,11AR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11A-hexahydro[1,3]oxazolo[3,2-A]pyrido[1,2-D]pyrazine-8-carboxamides as HIV agents
SHIONOGI & CO0 citations51
US9365587B2Jun 14, 2016
Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
SHIONOGI & CO0 citations51
US9133216B2Sep 15, 2015
(3S,11aR)-6-[(phenylmethyl)oxy]-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-9 and/or (3S,11aR)-6-[(phenymethyl)oxy]-8-bromo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-10
SHIONOGI & CO0 citations51
US8981129B2Mar 17, 2015
2-(2-hydroxy-2-phenylethyl)-3-[(phenylmethyl)oxy]-4H-pyran-4-one of the formula P-3 and/or 2-[(E)-2-phenylethenyl]-3-[(phenylmethyl)oxy]-4H-Pyran-4-one of the formula P-4
SHIONOGI & CO0 citations51
US8754214B2Jun 17, 2014
Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
SHIONOGI & CO0 citations51
GLAXOSMITHKLINE LLC
4 patentsUS9102685B2Aug 11, 2015
Derivatives of betulin
GLAXOSMITHKLINE LLC8 citations84
US10064873B2Sep 4, 2018
Compounds and compositions for treating HIV with derivatives of Betulin
GLAXOSMITHKLINE LLC0 citations52
US9795619B2Oct 24, 2017
Pharmaceutical compositions
GLAXOSMITHKLINE LLC1 citations45
US9340513B2May 17, 2016
Propenoate derivatives of betulin
GLAXOSMITHKLINE LLC0 citations42